Human Microbiome Therapeutics Market Analysis Unveils Key Segments and Competitive Landscape
Market Overview Global human microbiome therapeutics market size and share is currently valued at USD 508.70 million in 2022 and is anticipated to generate an estimated revenue of USD 3,917.01 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 22.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2023 - 2032 The human microbiome therapeutics landscape is rapidly evolving, encompassing fecal microbiota transplantation (FMT), probiotics, prebiotics, synbiotics, postbiotics, and live biotherapeutic products (LBPs). These interventions aim to restore microbial balance in the body, particularly within the gut, where trillions of bacteria play crucial roles in digestion, immunity, and overall well-being. As research continues to uncover the intricate connections between the microbiome and various physiological systems, the development of targeted microbiome-based treatments...